rs1130866
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000542.5(SFTPB):c.392C>T(p.Thr131Ile) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.517 in 1,612,412 control chromosomes in the GnomAD database, including 220,173 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_000542.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SFTPB | NM_000542.5 | c.392C>T | p.Thr131Ile | missense_variant, splice_region_variant | 4/11 | ENST00000519937.7 | NP_000533.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SFTPB | ENST00000519937.7 | c.392C>T | p.Thr131Ile | missense_variant, splice_region_variant | 4/11 | 1 | NM_000542.5 | ENSP00000428719 | P1 |
Frequencies
GnomAD3 genomes AF: 0.567 AC: 85877AN: 151492Hom.: 25579 Cov.: 30
GnomAD3 exomes AF: 0.495 AC: 124356AN: 251164Hom.: 32253 AF XY: 0.495 AC XY: 67144AN XY: 135734
GnomAD4 exome AF: 0.512 AC: 747528AN: 1460802Hom.: 194575 Cov.: 48 AF XY: 0.511 AC XY: 371138AN XY: 726722
GnomAD4 genome AF: 0.567 AC: 85936AN: 151610Hom.: 25598 Cov.: 30 AF XY: 0.562 AC XY: 41612AN XY: 74088
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 13, 2013 | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 05, 2016 | - - |
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 22, 2018 | This variant is associated with the following publications: (PMID: 23330012, 11076040, 26620227) - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Surfactant metabolism dysfunction, pulmonary, 1 Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Mar 06, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Hereditary pulmonary alveolar proteinosis Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2015 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at